These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1926868)
61. [Cellular biology of the vascular wall and arteriosclerosis]. Dartsch PC Verh Dtsch Ges Inn Med; 1991; 97():573-82. PubMed ID: 1808948 [No Abstract] [Full Text] [Related]
62. Physiological role of vessel wall related antithrombotic mechanisms: contribution of endogenous and exogenous heparin-like components to the anticoagulant potential of the endothelium. Preissner KT Haemostasis; 1990; 20 Suppl 1():30-49. PubMed ID: 2083871 [TBL] [Abstract][Full Text] [Related]
63. The anticoagulant role of heparin-like molecules in the endothelial cell surface in hemostasis--endothelial heparin-like molecules. Shimada K; Ozawa T Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1604-9. PubMed ID: 3551438 [No Abstract] [Full Text] [Related]
64. [Modern views of the role of heparin in hemostasis and regulation of enzymatic and hormonal activities]. Kondashevskaia MV Vestn Ross Akad Med Nauk; 2010; (7):35-43. PubMed ID: 20795401 [TBL] [Abstract][Full Text] [Related]
65. Hemostatic properties of normal and perturbed vascular cells. Rodgers GM FASEB J; 1988 Feb; 2(2):116-23. PubMed ID: 3277885 [TBL] [Abstract][Full Text] [Related]
66. [Heparin and the arterial wall]. Manciet G; Decamps A; Bourdel I; Emeriau JP; Galley P Ann Cardiol Angeiol (Paris); 1991 Jun; 40(6):385-9. PubMed ID: 1859146 [No Abstract] [Full Text] [Related]
67. Glycosaminoglycans contribute to multiple functions of vascular endothelial cells. Cockwell P; Adams DH; Savage CO Clin Exp Immunol; 1996 Apr; 104(1):1-3. PubMed ID: 8603512 [No Abstract] [Full Text] [Related]
68. The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development. Elsayed E; Becker RC J Thromb Thrombolysis; 2003 Feb; 15(1):11-8. PubMed ID: 14574071 [TBL] [Abstract][Full Text] [Related]
69. [The principal mechanisms of thrombosis (report I). Mechanisms of vascular wall thromboresistance]. Hereliuk IP; Hereliuk VI Klin Khir; 1998; (7):50-2. PubMed ID: 9989095 [No Abstract] [Full Text] [Related]
70. Thromboresistance of the arterial wall: the role of heparin and glycosaminoglycans. Bianciardi G; Frigidi E; Palummo N; Simoes C; Tanganelli P; Weber G Wien Klin Wochenschr; 1991; 103(14):412-5. PubMed ID: 1926868 [TBL] [Abstract][Full Text] [Related]
72. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Rosenberg RD Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697 [TBL] [Abstract][Full Text] [Related]
73. Arterial wall-determined risk factors to vascular diseases: a nonhuman primate model. Wang XL; Wang J; Shi Q; Carey KD; VandeBerg JL Cell Biochem Biophys; 2004; 40(3):371-88. PubMed ID: 15211033 [TBL] [Abstract][Full Text] [Related]
74. Endothelial cell influences on vascular smooth muscle phenotype. Campbell JH; Campbell GR Annu Rev Physiol; 1986; 48():295-306. PubMed ID: 3518616 [No Abstract] [Full Text] [Related]
75. [Review: heparin. 2. Effect on thrombocytes, vascular walls and fibrinolysis]. Kase F; PospĂsil J; Hlousková D Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):905-15. PubMed ID: 1713897 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]